What we do Vinati Organics Ltd manufactures specialty organic intermediates, monomers, and polymers with leadership in Isobutyl Benzene and ATBS production globally. |
Founded in 1,989 |
Market share World's largest producer of Isobutyl Benzene and ATBS; India's largest in IsoButylene and Butyl Phenols. |
Problem solved Supplies critical chemical intermediates for pharmaceuticals and specialty chemicals, enabling production of drugs like ibuprofen and enhancing industrial chemical processes. |
Top clients or who we serve Serves pharmaceutical, specialty chemicals, and personal care industries globally with a B2B business model. |
Key management Ms. Vinati Saraf Mutreja (MD & CEO) leads with a reputed management team driving innovation and growth. |
Our journey and innovations Founded in 1989; pioneered production of rare sulfonic acid monomers; diversified products and expanded renewable energy usage; launched U.S. subsidiary in 2025. |
Where we operate India and international markets including exports; recent expansion into U.S. market via subsidiary. |
Top products or what we offer Specialty chemicals like Isobutyl Benzene, ATBS, IsoButylene, Butyl Phenols, HPMTBE, and personal care additives. |
Top brands Isobutyl Benzene - global leader; ATBS - third globally; HPMTBE - high purity offering; Butyl Phenols - key pharmaceutical raw material. |
Raw materials needed Petroleum derivatives and chemicals for specialty organic synthesis pathways. |
Raw materials supplier Sourced from major petrochemical suppliers with long-term procurement arrangements. |
Recurring vs cyclical contribution Revenue is largely recurring due to steady pharmaceutical and specialty chemical client demand. |
Our industry position Market leader in select specialty chemicals with competitive strengths in production scale and product purity. |
Financial highlights FY 2024-25 revenue: Rs 2248 crore; net profit: Rs 405 crore; revenue growth ~18%; strong EBITDA margin of 23%. |
Geographical revenue split India contributes approx 30%, international markets 70% of revenue. |
Order book Not specifically disclosed; consistent order flow from established industrial clients. |
Whats driving growth Innovation in specialty chemicals, capacity expansions, renewable energy integration, and diversification into U.S. markets. |
Our future plans Capex of Rs 300 crore for capacity enhancement, new product lines, and downstream integration. |
Our green promise Installed multiple solar power plants totaling over 30 MW, emphasizing sustainability and energy efficiency. |
Our people and values 1283 permanent employees; culture focuses on ethics, quality, and diversity including gender representation on board. |
Key challenges ahead Raw material price volatility, regulatory compliance, and market competition risks. |
Interesting facts One of only three global producers of ATBS; consistently repays long-term debt fully; awarded Most Promising Company by CNBC-TV18 in 2020. |
Risks and strategy Mitigates supply chain risk with partnerships; focuses on R&D and geographic diversification to sustain growth. |
